Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Catherine A Seamon"'
Autor:
Katherine E Clarridge, Jana Blazkova, Kevin Einkauf, Mary Petrone, Eric W Refsland, J Shawn Justement, Victoria Shi, Erin D Huiting, Catherine A Seamon, Guinevere Q Lee, Xu G Yu, Susan Moir, Michael C Sneller, Mathias Lichterfeld, Tae-Wook Chun
Publikováno v:
PLoS Pathogens, Vol 14, Iss 1, p e1006792 (2018)
Therapeutic strategies aimed at achieving antiretroviral therapy (ART)-free HIV remission in infected individuals are under active investigation. Considering the vast majority of HIV-infected individuals experience plasma viral rebound upon cessation
Externí odkaz:
https://doaj.org/article/45496f66b1e943179ffa52f4f100a017
Autor:
Felipe Lopes de Assis, Kenneth B. Hoehn, Xiaozhen Zhang, Lela Kardava, Connor D. Smith, Omar El Merhebi, Clarisa M. Buckner, Krittin Trihemasava, Wei Wang, Catherine A. Seamon, Vicky Chen, Paul Schaughency, Foo Cheung, Andrew J. Martins, Chi-I Chiang, Yuxing Li, John S. Tsang, Tae-Wook Chun, Steven H. Kleinstein, Susan Moir
Publikováno v:
Cell Reports, Vol 42, Iss 7, Pp 112780- (2023)
Summary: Protective immunity following vaccination is sustained by long-lived antibody-secreting cells and resting memory B cells (MBCs). Responses to two-dose SARS-CoV-2 mRNA-1273 vaccination are evaluated longitudinally by multimodal single-cell an
Externí odkaz:
https://doaj.org/article/0741d21fc63c4181b8b82bf41955424e
Autor:
Chun-Shu Wong, Clarisa M. Buckner, Silvia Lucena Lage, Luxin Pei, Felipe L. Assis, Eric W. Dahlstrom, Sarah L. Anzick, Kimmo Virtaneva, Adam Rupert, Jeremy L. Davis, Ting Zhou, Elizabeth Laidlaw, Maura Manion, Frances Galindo, Megan Anderson, Catherine A. Seamon, Michael C. Sneller, Andrea Lisco, Claire Deleage, Stefania Pittaluga, Susan Moir, Irini Sereti
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Low nadir CD4 T-cell counts in HIV+ patients are associated with high morbidity and mortality and lasting immune dysfunction, even after antiretroviral therapy (ART). The early events of immune recovery of T cells and B cells in severely lymphopenic
Externí odkaz:
https://doaj.org/article/0ae51d691b0641559c9ba2d6466a68a7
Autor:
Clarisa M. Buckner, Lela Kardava, Omar El Merhebi, Sandeep R. Narpala, Leonid Serebryannyy, Bob C. Lin, Wei Wang, Xiaozhen Zhang, Felipe Lopes de Assis, Sophie E.M. Kelly, I-Ting Teng, Genevieve E. McCormack, Lauren H. Praiss, Catherine A. Seamon, M. Ali Rai, Heather Kalish, Peter D. Kwong, Michael A. Proschan, Adrian B. McDermott, Anthony S. Fauci, Tae-Wook Chun, Susan Moir
Publikováno v:
medRxiv : the preprint server for health sciences.
SUMMARYSARS-CoV-2 mRNA booster vaccines provide protection from severe disease, eliciting strong immunity that is further boosted by previous infection. However, it is unclear whether these immune responses are affected by the interval between infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e362e95d2f3727a809ce8fbae6270235
https://pubmed.ncbi.nlm.nih.gov/36257313
https://pubmed.ncbi.nlm.nih.gov/36257313
Autor:
Lela Kardava, Nicholas Rachmaninoff, William W. Lau, Clarisa M. Buckner, Krittin Trihemasava, Jana Blazkova, Felipe Lopes de Assis, Wei Wang, Xiaozhen Zhang, Yimeng Wang, Chi-I Chiang, Sandeep Narpala, Genevieve E. McCormack, Can Liu, Catherine A. Seamon, Michael C. Sneller, Sarah O’Connell, Yuxing Li, Adrian B. McDermott, Tae-Wook Chun, Anthony S. Fauci, John S. Tsang, Susan Moir
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective at inducing protective immunity. However, weak antibody responses are seen in some individuals, and cellular correlates of immunit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f12be89d77240e41614b6e9a660dab95
https://doi.org/10.1073/pnas.2204607119
https://doi.org/10.1073/pnas.2204607119
Autor:
Clarisa M. Buckner, Lela Kardava, Omar El Merhebi, Sandeep R. Narpala, Leonid Serebryannyy, Bob C. Lin, Wei Wang, Xiaozhen Zhang, Felipe Lopes de Assis, Sophie E.M. Kelly, I-Ting Teng, Genevieve E. McCormack, Lauren H. Praiss, Catherine A. Seamon, M. Ali Rai, Heather Kalish, Peter D. Kwong, Michael A. Proschan, Adrian B. McDermott, Anthony S. Fauci, Tae-Wook Chun, Susan Moir
Publikováno v:
Cell. 185:4333-4346.e14
SARS-CoV-2 mRNA booster vaccines provide protection from severe disease, eliciting strong immunity that is further boosted by previous infection. However, it is unclear whether these immune responses are affected by the interval between infection and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb3db61d49b47bbb411be4f5ec1f7f9b
https://doi.org/10.1016/j.cell.2022.09.032
https://doi.org/10.1016/j.cell.2022.09.032